Elrexfio

Active Ingredient(s): Elranatamab
FDA Approved: * August 14, 2023
Pharm Company: * PFIZER INC
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Elrexfio 44 mg/1.1ml Subcutaneous Injection, Solution
NDC: 0069-2522
Labeler:
Pfizer Laboratories Div Pfizer Inc
Elrexfio 76 mg/1.9ml Subcutaneous Injection, Solution
NDC: 0069-4494
Labeler:
Pfizer Laboratories Div Pfizer Inc
Elrexfio 44 mg/1.1ml Subcutaneous Injection, Solution
NDC: 63539-252
Labeler:
U.S. Pharmaceuticals